Physician profile

Barry Peltzman

Periodontics · Columbia, MD

NPI 1730231739

$5,837.94

in general payments reported to CMS, 2019-2025

10 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$186.22

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Straumann USA LLC $1,667.39 2019-2020
Zimmer Biomet Holdings, INC. $1,588.57 2019-2021
A-Dec, INC. $1,485.00 2020
Zimvie INC. $562.90 2022-2024
Acteon INC $388.13 2020-2024
Salvin Dental Specialties, INC. $75.26 2019
Geistlich Pharma, North America, INC. $24.31 2020-2021
Patterson Companies, INC. $18.55 2024
3m Company $16.04 2019
Dentsply Ih INC. $11.79 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Barry Peltzman

$5,837.94

in general payments reported 2019-2025

Years
2019-2024
Top company
Straumann USA LLC

https://glasscript.com/doctor/124537/barry-peltzman

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.